Biography:
Arezou Sabbagh Hadi, PhD, is a researcher in Cancer Genetics and a current medical student, dedicated to advancing cancer therapeutics. Her expertise lies at the intersection of nanotechnology and molecular oncology, with a focus on developing novel drug delivery systems. Her seminal work involves the design and evaluation of graphene oxide-based nanocomposites for targeted colon cancer therapy, demonstrating significant efficacy in inducing apoptosis in cancer cells. She aims to bridge foundational research with clinical application to improve patient outcomes.
Title : A next-generation approach: Hesperetin-graphene oxide nanosheets as an innovative drug delivery system for colon cancer